| [1] |
Karunakaran M, Barreto SG. Surgery for pancreatic cancer: current controversies and challenges[J]. Future Oncol, 2021, 17(36): 5135-5162.
|
| [2] |
Latenstein AEJ, van Roessel S, van der Geest LGM, et al. Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model[J]. Ann Surg Oncol, 2020, 27(7): 2516-2524.
|
| [3] |
孙备，陈华，刘红阳．中国腹腔镜胰腺癌手术需要注意的几个问题[J/CD]．中华普外科手术学杂志（电子版）, 2022, 1(04): 360-363.
|
| [4] |
Leonhardt CS, Gustorff C, Klaiber U, et al. Prognostic Factors for Early Recurrence After Resection of Pancreatic Cancer: A Systematic Review and Meta-Analysis[J]. Gastroenterology, 2024, 167(5): 977-992.
|
| [5] |
James NE, Chidambaram S, Gall TM, et al. Quality of life after pancreatic surgery - A systematic review[J]. HPB (Oxford), 2022, 24(8): 1223-1237.
|
| [6] |
Kitano M, Gress TM, Garg PK, et al. International consensus guidelines on interventional endoscopy in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club [J]. Pancreatology, 2020, 20(6): 1045-1055.
|
| [7] |
Stoop TF, Theijse RT, Seelen LWF, et al. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer[J]. Nat Rev Gastroenterol Hepatol, 2024, 21(2): 101-124.
|
| [8] |
赵玉沛，邱江东. 中国腹腔镜胰腺癌根治术：20年回顾与展望[J/CD]. 中华普外科手术学杂志（电子版）, 2021, 15(03): 237-240.
|
| [9] |
Perri G, Prakash L, Katz MHG. Defining and Treating Borderline Resectable Pancreatic Cancer[J]. Curr Treat Options Oncol, 2020, 21(9): 71.
|
| [10] |
Kang MJ, Kim SW. Paradigm shift for defining the resectability of pancreatic cancer[J]. Ann Hepatobiliary Pancreat Surg, 2021, 25(4): 451-455.
|
| [11] |
Zhang XP, Xu S, Gao YX, et al. Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter study[J]. Int J Surg, 2023, 109(4): 785-793.
|
| [12] |
Skalicky P, Urban O, Ehrmann J, et al. The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2022, 166(4): 386-392.
|
| [13] |
Cai M, Guo T, Chen Z, et al. Development and validation of a network calculator model for safety and efficacy after pancreaticoduodenectomy in the elderly patients with pancreatic head cancer[J]. Cancer Med, 2023, 12(19): 19673-19689.
|
| [14] |
Ishida H, Ogura T, Takahashi A, et al. Optimal Region of Lymph Node Dissection in Distal Pancreatectomy for Left-Sided Pancreatic Cancer Based on Tumor Location[J]. Ann Surg Oncol, 2022, 29(4): 2414-2424.
|
| [15] |
Terasaki F, Sugiura T, Okamura Y, et al. Benefit of lymph node dissection for perihilar and distal cholangiocarcinoma according to lymph node stations[J]. J Hepatobiliary Pancreat Sci, 2024, 1(4): 251-261.
|
| [16] |
王伟，陈雪健，李宁，等. 胰头癌扩大根治术研究进展[J]. 现代肿瘤医学, 2022, 30(14): 2650-2653.
|
| [17] |
Coco D, Leanza S, Schillaci R, et al. Laparoscopic distal pancreatectomy for benign and malignant disease: a review of techniques and results[J]. Prz Gastroenterol, 2022, 17(2): 103-109.
|
| [18] |
Vasavada B, Patel H. Laparoscopic vs Open Pancreaticoduodenectomy-an Updated Meta-Analysis of Randomized Control Trials[J]. Indian J Surg Oncol, 2022, 13(4): 809-816.
|
| [19] |
Liu C, Liu Y, Dong J, et al. Laparoscopic pancreaticoduodenectomy versus open pancreaticoduodenectomy for carcinoma of the ampulla of Vater in a medium-volume center: a propensity score matching analysis[J]. J Int Med Res, 2023, 51(12): 3000605231219061.
|
| [20] |
Li L, Bo Z, Liu Q, et al. Comparative analysis of clinical efficacy between laparoscopic and open pancreaticoduodenectomy[J]. Medicine (Baltimore), 2023, 102(16): 33588.
|
| [21] |
吉韬，董仁华. 腹腔镜胰十二指肠切除术中腹膜后神经清扫在早期胰腺癌中的应用价值[J/CD]. 中华普外科手术学杂志（电子版）, 2021, 15(06): 672-675.
|
| [22] |
Bojmar L, Zambirinis CP, Hernandez JM, et al. Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer[J]. Nat Med, 2024, 30(8): 2170-2180.
|
| [23] |
Nakamura K, Notohara K, Nishizaki R, et al. Macroscopic qualitative evaluation of solid pancreatic lesion specimens from endoscopic ultrasound-guided fine needle aspiration/biopsies[J]. Pancreatology, 2023, 23(8): 1028-1035.
|
| [24] |
Imamura T, Yamamoto Y, Sugiura T, et al. Reconsidering the Optimal Regional Lymph Node Station According to Tumor Location for Pancreatic Cancer[J]. Ann Surg Oncol, 2021, 28(3): 1602-1611.
|
| [25] |
Yang AZ, Kongboonvijit S, Fernandez-Del Castillo CF, et al. Uncinate Duct Dilatation Predicts Additional Risk for High-Grade Dysplasia or Invasive Carcinoma Among Fukuoka-Positive Intraductal Papillary Mucinous Neoplasms[J]. Ann Surg, 2023, 277(6): 988-994.
|
| [26] |
Watanabe G, Ushida Y, Oba A, et al. Impact of Tumor Size on the Outcomes of Patients with Resectable Distal Pancreatic Cancer: Lessons Learned from a Series of 158 Radical Resections [J]. Ann Surg Oncol, 2022, 29(1): 378-388.
|
| [27] |
Hayasaki A, Mizuno S, Nagata M, et al. Extrapancreatic extension is a better adverse prognostic factor than tumor size in patients with localized pancreatic ductal adenocarcinoma treated with chemoradiotherapy-comparison of T category between the American Joint Committee on Cancer and Japan Pancreas Society [J]. HPB (Oxford), 2023, 25(10): 1268-1277.
|
| [28] |
Youssef FF, Liu L, Lin W, et al. Pancreatic cyst features predict future development of pancreatic cancer: results of a nested case-control study [J]. Gastrointest Endosc, 2024, 99(2): 1-9.
|
| [29] |
Cheng H, Xu JH, Kang XH, et al. Nomogram for predicting the preoperative lymph node metastasis in resectable pancreatic cancer[J]. J Cancer Res Clin Oncol, 2023, 149(13): 12469-12477.
|
| [30] |
Aysal A, Agalar C, Cagaptay S, et al. The Site of Lymph Node Metastasis: A Significant Prognostic Factor in Pancreatic Ductal Adenocarcinoma [J]. Turk Patoloji Derg, 2022, 38(3): 284-291.
|
| [31] |
Jiang D, Fan X, Li P, et al. Prediction scores of postoperative liver metastasis and long-term survival of pancreatic head cancer based on the distance between the mesenteric vessels and tumor, preoperative serum carbohydrate antigen 19-9 level, and lymph node metastasis rate [J]. Cancer Med, 2023, 12(2): 1064-1078.
|
| [32] |
Varshney VK. Pancreatic head cancer with different patterns of lymph node metastasis[J]. J Hepatobiliary Pancreat Sci, 2022, 29(11): 116.
|
| [33] |
Nießen A, Schimmack S, Lewosinska M, et al. Lymph node metastases and recurrence in pancreatic neuroendocrine neoplasms [J]. Surgery, 2022, 172(6): 1791-1799.
|
| [34] |
Ratnayake CBB, Shah N, Loveday B, et al. The Impact of the Depth of Venous Invasion on Survival Following Pancreatoduodenectomy for Pancreatic Cancer: a Meta-analysis of Available Evidence[J]. J Gastrointest Cancer, 2020, 51(2): 379-386.
|
| [35] |
Diener MK, Mihaljevic AL, Strobel O, et al. Periarterial divestment in pancreatic cancer surgery[J]. Surgery, 2021, 169(5): 1019-1025.
|
| [36] |
Torres SM, Vaz da Silva DG, Ribeiro HSC, et al. Short-term outcomes after vascular resection for pancreatic tumors: Lessons learned from 72 cases from a single Brazilian Cancer Center[J]. J Surg Oncol, 2020, 121(5): 857-862.
|
| [37] |
López JC, Ielpo B, Iglesias M, et al. The impact of vascular margin invasion on local recurrence after pancreatoduodenectomy in pancreatic adenocarcinoma[J]. Langenbecks Arch Surg, 2024, 409(1): 122.
|
| [38] |
Xue K, Huang X, Zhao P, et al. Perioperative and long-term survival outcomes of pancreatectomy with arterial resection in borderline resectable or locally advanced pancreatic cancer following neoadjuvant therapy: a systematic review and meta-analysis [J]. Int J Surg, 2023, 109(12): 4309-4321.
|
| [39] |
Zhu M, Luo F, Xu B, et al. Research Progress of Neural Invasion in Pancreatic Cancer[J]. Curr Cancer Drug Targets, 2024, 24(4): 397-410.
|
| [40] |
Cha DE, Yu AT, Khajoueinejad N, et al. Perineural Invasion of Pancreatic Ductal Adenocarcinoma is Associated with Early Recurrence after Neoadjuvant Therapy Followed by Resection [J]. World J Surg, 2023, 47(7): 1801-1808.
|
| [41] |
Crippa S, Pergolini I, Javed AA, et al. Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma[J]. Ann Surg, 2022, 276(2): 378-385.
|
| [42] |
Mueller TC, Henselmann M, Reischl S, et al. Associations of body composition parameters with postoperative outcome and perineural tumour invasion after oncological pancreatic resection [J]. BMC Surg, 2024, 24(1): 175.
|
| [43] |
Weyhe D, Obonyo D, Uslar VN, et al. Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data[J]. PLoS One, 2021, 16(3): 248633.
|
| [44] |
Kaltenmeier C, Nassour I, Hoehn RS, et al. Impact of Resection Margin Status in Patients with Pancreatic Cancer: a National Cohort Study [J]. J Gastrointest Surg, 2021, 25(9): 2307-2316.
|
| [45] |
Leonhardt CS, Niesen W, Kalkum E, et al. Prognostic relevance of the revised R status definition in pancreatic cancer: meta-analysis [J]. BJS Open, 2022, 6(2): 10.
|
| [46] |
Maeda S, Moore AM, Yohanathan L, et al. Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomy[J]. Surgery, 2020, 167(5): 803-811.
|